Β-lactamases: Difference between revisions
From IDWiki
Β-lactamases
(→) |
mNo edit summary |
||
| (14 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
== |
==Background== |
||
*Includes a spectrum of molecules that hydrolyze [[β-lactams]], from penicillins to carbapenems |
|||
* Bacteria containing a plasmid that codes for an extended-spectrum beta-lactamase (ESBL) |
|||
**See also [[extended-spectrum β-lactamases]] and [[carbapenemases]] |
|||
* Most common with ''Escherichia coli'' and ''Klebsiella'' |
|||
== Classification |
===Ambler Classification=== |
||
*Classification based on amino acid sequences rather than function |
|||
* '''Class A''' |
|||
** Constitutively expressed plasmid |
|||
** Most common ESBL in Gram-negative bacteria |
|||
** Resistance to 2nd and 3rd generation cephalosporins |
|||
** Examples include penicillinase, TEM-1 (common in GNBs), CTX-M, ''K. pneumoniae'' carbapenemase (KPC) family |
|||
** Common in ''[[E. coli]]'', ''[[Klebsiella]]'', and ''[[Proteus]]'' spp. |
|||
* '''Class B''': metallobetalactamases |
|||
** Examples include New Delhi metallo-beta-lactamase (NDM-1) |
|||
* '''Class C''': ampC |
|||
** Inducible AmpC gene present in the genome |
|||
** Common in ''[[Citrobacter]]'', ''[[Serratia]]'', and ''[[Enterobacter]]'' |
|||
* '''Class D''': OXA |
|||
** Common in ''[[Acinetobacter]]'' |
|||
{| class="wikitable" |
|||
== Management == |
|||
!Class |
|||
!Binding Site |
|||
!Examples |
|||
!Inhibitors |
|||
|- |
|||
|A |
|||
|serine |
|||
|TEM, SHV, KPC, CTX-M, GES |
|||
|clavulanic acid, tazobactam, avibactam, vaborbactam, relebactam |
|||
|- |
|||
|B |
|||
|metallo |
|||
|VIM, NDM, IMP |
|||
| |
|||
|- |
|||
|C |
|||
|serine |
|||
|AmpC, P99 |
|||
|avibactam, vaborbactam, relebactam |
|||
|- |
|||
|D |
|||
|serine |
|||
|OXA (oxacillinase) enzymes |
|||
|avibactam (OXA-48), ±clavulanic aciid |
|||
|} |
|||
====Serine β-lactamases==== |
|||
* Antibiotic therapy tailored to the resistance pattern |
|||
* Carbapenems, aminoglycosides, fluoroquinolones, and Septra typically work well |
|||
*'''Amber classes A, B, and C''' are the serine β-lactamases |
|||
*Contain a serine residue at the active site |
|||
*'''Class A''': inhibited by [[clavulanic acid]] or [[tazobactam]] |
|||
**Constitutively expressed plasmid |
|||
**Most common ESBL in [[Gram-negative bacteria]] |
|||
**Resistance to 2nd and 3rd generation [[cephalosporins]] |
|||
**Common in ''[[E. coli]]'', ''[[Klebsiella]]'', and ''[[Proteus]]'' spp. |
|||
**Examples include: |
|||
***Penicillinases: TEM-1 (common in GNBs), SHV-1 |
|||
***ESBLs: CTX-M, TEM-3 |
|||
***Carbapenemases: ''K. pneumoniae'' carbapenemase (KPC) |
|||
*'''Class C''': not inhibited by [[clavulanic acid]] or EDTA, resistant to [[cefoxitin]], inhibited by [[cloxicillin]] in vitro |
|||
**AmpC = chromosomal |
|||
**Often an inducible AmpC gene present in the genome |
|||
**Common in ''[[Citrobacter]]'', ''[[Serratia]]'', and ''[[Enterobacter]]'' |
|||
*'''Class D''': not inhibited by EDTA, variably inhibited by [[clavulanic acid]]; hard to identify |
|||
**Common in ''[[Pseudomonas]]'' |
|||
**Difficult to detect with routine screening |
|||
**Examples include: |
|||
***ESBLs: OXA-11 |
|||
***Carbapenemases: OXA-23, OXA-48 |
|||
====Metallo-β-lactamases==== |
|||
*'''Ambler Class B''' are the metallo-β-lactamases |
|||
*Contain a zinc ion at the active site |
|||
*Inhibited by EDTA, not inhibited by [[clavulanic acid]] |
|||
*Examples include: |
|||
**Carbapenemases: |
|||
***New Delhi metallo-beta-lactamase (NDM-1) |
|||
***Imipenemases (IMP) |
|||
***Verona integron-encoded metallo-β-lactamases (VIM) |
|||
***L1 β-lactamase, present in the [[Stenotrophomonas maltophilia]] chromosome |
|||
===Bush-Jacoby Classification=== |
|||
{| class="wikitable" |
|||
! rowspan="2" |Group |
|||
! rowspan="2" |Ambler |
|||
! rowspan="2" |Substrates |
|||
! colspan="2" |Inhibitors |
|||
! rowspan="2" |Definition |
|||
! rowspan="2" |Examples |
|||
|- |
|||
!CA/TZB |
|||
!EDTA |
|||
|- |
|||
! colspan="7" |Group 1: Cephalosporinases |
|||
|- |
|||
|1 |
|||
| rowspan="2" |C |
|||
|[[cephalosporins]] |
|||
|— |
|||
|— |
|||
|hydrolyzes cephalosporins better than benzylpenicillin, and hydrolyzes cephamycins |
|||
|''E. coli'' AmpC, P99, ACT-1, CMY-2, FOX-1, MIR-1 |
|||
|- |
|||
| |
|||
|[[cephalosporins]] |
|||
|— |
|||
|— |
|||
|increased hydrolysis of ceftazidime and other oxyimino-β-lactams |
|||
|GC1, CMY-37 |
|||
|- |
|||
! colspan="7" |Group 2: β-Lactamases |
|||
|- |
|||
|2a |
|||
| rowspan="7" |A |
|||
|[[penicillins]] |
|||
|yes |
|||
|— |
|||
|hydrolyzes benzylpenicillin better than cephalosporins |
|||
|PC1 |
|||
|- |
|||
|2b |
|||
|[[penicillins]] and early [[cephalosporins]] |
|||
|yes |
|||
|— |
|||
|hydrolyzes benzylpenicillin similar to cephalosporins |
|||
|TEM-1, TEM-2, SHV-1 |
|||
|- |
|||
|2be |
|||
|extended-spectrum [[cephalosporins]], [[monobactams]] |
|||
|yes |
|||
|— |
|||
|increased hydrolysis of oxyimino-β-lactams (third-generation plus monobactams) |
|||
|TEM-3, SHV-2, CTX-M-15, PER-1, VEB-1 |
|||
|- |
|||
|2br |
|||
|[[penicillins]] |
|||
|— |
|||
|— |
|||
|resistance to clavulanic acid, sulbactam, and tazobactam |
|||
|TEM-30, SHV-10 |
|||
|- |
|||
|2ber |
|||
|extended-spectrum [[cephalosporins]], [[monobactams]] |
|||
|— |
|||
|— |
|||
|increased hydrolysis of oxyimino-β-lactams plus resistance to clavulanic acid, sulbactam, and tazobactam |
|||
|TEM-50 |
|||
|- |
|||
|2c |
|||
|[[carbenicillin]] |
|||
|yes |
|||
|— |
|||
|increased hydrolysis of carbenicillin |
|||
|PSE-1, CARB-3 |
|||
|- |
|||
|2ce |
|||
|[[carbenicillin]], [[cefepime]] |
|||
|yes |
|||
|— |
|||
|increased hydrolysis of carbenicillin, cefepime, and cefpirome |
|||
|RTG-4 |
|||
|- |
|||
|2d |
|||
| rowspan="3" |D |
|||
|[[cloxacillin]] |
|||
|variable |
|||
|— |
|||
|increased hydrolysis of cloxacillin or oxacillin |
|||
|OXA-1, OXA-10 |
|||
|- |
|||
|2de |
|||
|extended-spectrum [[cephalosporins]] |
|||
|variable |
|||
|— |
|||
|hydrolyzes cloxacillin or oxacillin and oxyimino-β-lactams |
|||
|OXA-11, OXA-15 |
|||
|- |
|||
|2df |
|||
|[[carbapenems]] |
|||
|variable |
|||
|— |
|||
|hydrolyzes cloxacillin or oxacillin and carbapenems |
|||
|OXA-23, OXA-48 |
|||
|- |
|||
|2e |
|||
| rowspan="2" |A |
|||
|extended-spectrum [[cephalosporins]] |
|||
|yes |
|||
|— |
|||
|hydrolyzes cephalosporins, and inhibited by clavulanic acid but not aztreonem |
|||
|CepA |
|||
|- |
|||
|2f |
|||
|[[carbapenems]] |
|||
|variable |
|||
|— |
|||
|increased hydrolysis of carbapenems, oxyimino-β-lactams, cephamycins |
|||
|KPC-2, IMI-1, SME-1 |
|||
|- |
|||
! colspan="7" |Group 3: Carbapenemases |
|||
|- |
|||
|3a |
|||
| rowspan="2" |B |
|||
|[[carbapenems]] |
|||
|— |
|||
|yes |
|||
|broad-spectrum hydrolysis including carbapenems but not monobactams |
|||
|IMP-1, VIM-1, CcrA, IND-1, L1, CAU-1, GOB-1, FEZ-1 |
|||
|- |
|||
|3b |
|||
|[[carbapenems]] |
|||
|— |
|||
|yes |
|||
|preferential hydrolysis of carbapenems |
|||
|CphA, Sfh-1 |
|||
|} |
|||
===Epidemiology=== |
|||
*The most common β-lactamase is TEM-1 |
|||
*The most common carbapenemases in the US are KPCs, followed by NDM and OXA-48-like carbapenemases |
|||
== Common β-Lactamases == |
|||
{| class="wikitable" |
|||
!β-lactamase[[CiteRef::cantón2008ir]] |
|||
!AMX |
|||
!AMC |
|||
!TIC |
|||
!TIM |
|||
!PIP |
|||
!TZP |
|||
!CFZ |
|||
!FOX |
|||
!CRO |
|||
|- |
|||
|TEM-1 |
|||
|R |
|||
|S |
|||
|R |
|||
|S |
|||
|I/R |
|||
|S |
|||
|S/I/R |
|||
|S |
|||
|S |
|||
|- |
|||
|TEM-1 hyperproduction |
|||
|R |
|||
|I/R |
|||
|R |
|||
|I/R |
|||
|R |
|||
|S/I/R |
|||
|I/R |
|||
|S |
|||
|S |
|||
|- |
|||
|OXA-1 |
|||
|R |
|||
|I/R |
|||
|R |
|||
|I/R |
|||
|R |
|||
|I/R |
|||
|R |
|||
|S |
|||
|S |
|||
|- |
|||
|IRT type |
|||
|R |
|||
|I/R |
|||
|I/R |
|||
|I/R |
|||
|S/I/R |
|||
|S/I/R |
|||
|S |
|||
|S |
|||
|S |
|||
|- |
|||
|CMT type |
|||
|R |
|||
|R |
|||
|R |
|||
|I/R |
|||
|R |
|||
|I/R |
|||
|I/R |
|||
|S |
|||
|I/R |
|||
|- |
|||
|ESBL type |
|||
|R |
|||
|S/I |
|||
|R |
|||
|S |
|||
|I/R |
|||
|S/I |
|||
|R |
|||
|S |
|||
|R |
|||
|- |
|||
|[[AmpC β-lactamase|AmpC hyperproduction]] |
|||
|R |
|||
|R |
|||
|I/R |
|||
|I/R |
|||
|I/R |
|||
|I/R |
|||
|R |
|||
|I/R |
|||
|S/I/R |
|||
|} |
|||
==Management== |
|||
*Antibiotic therapy tailored to the resistance pattern |
|||
*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well |
|||
*See also [[Carbapenem-resistant organisms]] |
|||
==Further Reading== |
|||
*Updated Functional Classification of β-Lactamases. ''Antimicrob Agents Chemother''. 2010;54(3):969-976. doi: [https://doi.org/10.1128/AAC.01009-09 10.1128/AAC.01009-09] |
|||
{{DISPLAYTITLE:β-lactamases}} |
|||
[[Category:Antibiotics]] |
[[Category:Antibiotics]] |
||
Latest revision as of 17:46, 19 September 2024
Background
- Includes a spectrum of molecules that hydrolyze β-lactams, from penicillins to carbapenems
- See also extended-spectrum β-lactamases and carbapenemases
Ambler Classification
- Classification based on amino acid sequences rather than function
| Class | Binding Site | Examples | Inhibitors |
|---|---|---|---|
| A | serine | TEM, SHV, KPC, CTX-M, GES | clavulanic acid, tazobactam, avibactam, vaborbactam, relebactam |
| B | metallo | VIM, NDM, IMP | |
| C | serine | AmpC, P99 | avibactam, vaborbactam, relebactam |
| D | serine | OXA (oxacillinase) enzymes | avibactam (OXA-48), ±clavulanic aciid |
Serine β-lactamases
- Amber classes A, B, and C are the serine β-lactamases
- Contain a serine residue at the active site
- Class A: inhibited by clavulanic acid or tazobactam
- Constitutively expressed plasmid
- Most common ESBL in Gram-negative bacteria
- Resistance to 2nd and 3rd generation cephalosporins
- Common in E. coli, Klebsiella, and Proteus spp.
- Examples include:
- Penicillinases: TEM-1 (common in GNBs), SHV-1
- ESBLs: CTX-M, TEM-3
- Carbapenemases: K. pneumoniae carbapenemase (KPC)
- Class C: not inhibited by clavulanic acid or EDTA, resistant to cefoxitin, inhibited by cloxicillin in vitro
- AmpC = chromosomal
- Often an inducible AmpC gene present in the genome
- Common in Citrobacter, Serratia, and Enterobacter
- Class D: not inhibited by EDTA, variably inhibited by clavulanic acid; hard to identify
- Common in Pseudomonas
- Difficult to detect with routine screening
- Examples include:
- ESBLs: OXA-11
- Carbapenemases: OXA-23, OXA-48
Metallo-β-lactamases
- Ambler Class B are the metallo-β-lactamases
- Contain a zinc ion at the active site
- Inhibited by EDTA, not inhibited by clavulanic acid
- Examples include:
- Carbapenemases:
- New Delhi metallo-beta-lactamase (NDM-1)
- Imipenemases (IMP)
- Verona integron-encoded metallo-β-lactamases (VIM)
- L1 β-lactamase, present in the Stenotrophomonas maltophilia chromosome
- Carbapenemases:
Bush-Jacoby Classification
| Group | Ambler | Substrates | Inhibitors | Definition | Examples | |
|---|---|---|---|---|---|---|
| CA/TZB | EDTA | |||||
| Group 1: Cephalosporinases | ||||||
| 1 | C | cephalosporins | — | — | hydrolyzes cephalosporins better than benzylpenicillin, and hydrolyzes cephamycins | E. coli AmpC, P99, ACT-1, CMY-2, FOX-1, MIR-1 |
| cephalosporins | — | — | increased hydrolysis of ceftazidime and other oxyimino-β-lactams | GC1, CMY-37 | ||
| Group 2: β-Lactamases | ||||||
| 2a | A | penicillins | yes | — | hydrolyzes benzylpenicillin better than cephalosporins | PC1 |
| 2b | penicillins and early cephalosporins | yes | — | hydrolyzes benzylpenicillin similar to cephalosporins | TEM-1, TEM-2, SHV-1 | |
| 2be | extended-spectrum cephalosporins, monobactams | yes | — | increased hydrolysis of oxyimino-β-lactams (third-generation plus monobactams) | TEM-3, SHV-2, CTX-M-15, PER-1, VEB-1 | |
| 2br | penicillins | — | — | resistance to clavulanic acid, sulbactam, and tazobactam | TEM-30, SHV-10 | |
| 2ber | extended-spectrum cephalosporins, monobactams | — | — | increased hydrolysis of oxyimino-β-lactams plus resistance to clavulanic acid, sulbactam, and tazobactam | TEM-50 | |
| 2c | carbenicillin | yes | — | increased hydrolysis of carbenicillin | PSE-1, CARB-3 | |
| 2ce | carbenicillin, cefepime | yes | — | increased hydrolysis of carbenicillin, cefepime, and cefpirome | RTG-4 | |
| 2d | D | cloxacillin | variable | — | increased hydrolysis of cloxacillin or oxacillin | OXA-1, OXA-10 |
| 2de | extended-spectrum cephalosporins | variable | — | hydrolyzes cloxacillin or oxacillin and oxyimino-β-lactams | OXA-11, OXA-15 | |
| 2df | carbapenems | variable | — | hydrolyzes cloxacillin or oxacillin and carbapenems | OXA-23, OXA-48 | |
| 2e | A | extended-spectrum cephalosporins | yes | — | hydrolyzes cephalosporins, and inhibited by clavulanic acid but not aztreonem | CepA |
| 2f | carbapenems | variable | — | increased hydrolysis of carbapenems, oxyimino-β-lactams, cephamycins | KPC-2, IMI-1, SME-1 | |
| Group 3: Carbapenemases | ||||||
| 3a | B | carbapenems | — | yes | broad-spectrum hydrolysis including carbapenems but not monobactams | IMP-1, VIM-1, CcrA, IND-1, L1, CAU-1, GOB-1, FEZ-1 |
| 3b | carbapenems | — | yes | preferential hydrolysis of carbapenems | CphA, Sfh-1 | |
Epidemiology
- The most common β-lactamase is TEM-1
- The most common carbapenemases in the US are KPCs, followed by NDM and OXA-48-like carbapenemases
Common β-Lactamases
| β-lactamase1 | AMX | AMC | TIC | TIM | PIP | TZP | CFZ | FOX | CRO |
|---|---|---|---|---|---|---|---|---|---|
| TEM-1 | R | S | R | S | I/R | S | S/I/R | S | S |
| TEM-1 hyperproduction | R | I/R | R | I/R | R | S/I/R | I/R | S | S |
| OXA-1 | R | I/R | R | I/R | R | I/R | R | S | S |
| IRT type | R | I/R | I/R | I/R | S/I/R | S/I/R | S | S | S |
| CMT type | R | R | R | I/R | R | I/R | I/R | S | I/R |
| ESBL type | R | S/I | R | S | I/R | S/I | R | S | R |
| AmpC hyperproduction | R | R | I/R | I/R | I/R | I/R | R | I/R | S/I/R |
Management
- Antibiotic therapy tailored to the resistance pattern
- Carbapenems, aminoglycosides, fluoroquinolones, and TMP-SMX typically work well
- See also Carbapenem-resistant organisms
Further Reading
- Updated Functional Classification of β-Lactamases. Antimicrob Agents Chemother. 2010;54(3):969-976. doi: 10.1128/AAC.01009-09
References
- ^ R. Cantón, M.I. Morosini, O. Martin, S. de la Maza, E. Gomez G. de la Pedrosa. IRT and CMT β-lactamases and inhibitor resistance. Clinical Microbiology and Infection. 2008;14:53-62. doi:10.1111/j.1469-0691.2007.01849.x.
